00000nam 2200000za 4500 9.856574 CaOODSP 20221107155550 cr ||||||||||| 180515s2018 oncd ob f000 0 eng d CaOODSP eng n-cn--- YN5-156/2018E-PDF Patent restoration and the cost of pharmaceuticals [electronic resource]. Ottawa : Office of the Parliamentary Budget Officer, 2018. 41 p. : col. charts Issued also in French under title: La prolongation de la durée des brevets et le coût des médicaments. Cover title. "26 April 2018." Includes bibliographical references. "This report estimates additional drug costs to Canadian consumers from changes to the Patent Law as negotiated under the Canada-European Union Comprehensive Economic and Trade Agreement (CETA). A two-year certificate of supplementary protection (CSP; elsewhere termed patent restoration, and used synonymously here since CSP provides patent-like protection) will delay the introduction of generic alternatives, and likely keep prices higher than they otherwise would be. The report also estimates the fiscal cost to the federal government of compensating provinces for increased costs to provincial public drug programs”--Verso of cover. Drugs Prices Patent extensions Government policy Canada. Office of the Parliamentary Budget Officer. La prolongation de la durée des brevets et le coût des médicaments (CaOODSP)9.856575 PDF 606 KB https://publications.gc.ca/collections/collection_2018/dpb-pbo/YN5-156-2018-eng.pdf